Viewing Study NCT02707861


Ignite Creation Date: 2025-12-24 @ 1:05 PM
Ignite Modification Date: 2025-12-28 @ 11:36 AM
Study NCT ID: NCT02707861
Status: COMPLETED
Last Update Posted: 2021-03-11
First Post: 2016-03-08
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1
Sponsor: TaiMed Biologics Inc.
Organization: